Sympathetic Nervous System Function as Measured by I-123 Metaiodobenzylguanidine Predicts Transplant-Free Survival in Heart Failure Patients With Idiopathic Dilated Cardiomyopathy

Journal of Cardiac Failure

Volumn 9, Issue 5, 2003, Pages 384-391

  Gerson, Myron C ^a,b   McGuire, Nancy ^a   Wagoner, Lynne E ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Congestive heart failure; Maximum oxygen consumption; Prognosis

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; NORADRENALIN;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE COURSE; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; MALE; MEASUREMENT; MEDIASTINUM; MORTALITY; NERVE CONDUCTION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; SYMPATHETIC NERVE;

EID: 0242268064     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1054/S1071-9164(03)00134-9     Document Type: Article

References (19)

1. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-23.
2. Sisson JC, Wieland DM, Sherman P, Mangner TJ, Tobes MC, Jacques S Jr. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med 1987;28:1620-4.
3. Merlet P, Benvenuti C, Moyse D, Pouillart F, Dubois-Rande J-L, Duval A-M, et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 1999;40:917-23.
4. 2-adrenergic receptor determine exercise capacity in patients with heart failure. Circ Res 2000;86:834-40.
5. 123I-MIBG). In Emran AM, editor. Chemists' view of imaging centers. New York: Plenum Press; 1995. p. 291-5
6. 123]m-iodobenzylguanidine. Appl Radiat Isot 1988;39:939-42.
7. Gerson MC, Craft LL, McGuire N, Suresh DP, Abraham WT, Wagoner LE. Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by I-123 metaiodobenzylguanidine. J Nucl Cardiol. 2002;9:608-15.
8. Imamura Y, Ando H, Mitsuoka W, Egashira S, Masaki H, Ashihara T, et al. Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure in-dependent of underlying cause. J Am Coll Cardiol 1995;26:1594-9.
9. American Heart Association. 2002 heart and stroke statistical update. Dallas, TX: American Heart Association; 2001, p. 19.
10. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med 1999;341:577-85.
11. Murata K, Kusachi S, Murakami T, Nogami K, Murakami M, Hirohata S, et al. Relation of iodine-123 metaiodobenzylguanidine myocardial scintigraphy to endomyocardial biopsy findings in patients with dilated cardiomyopathy. Clin Cardiol 1997;20:61-6.
12. Cohen-Solal A, Esanu Y, Logeart D, Pessione F, Dubois C, Dreyfus G, et al. Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis. J Am Coll Cardiol 1999;33:759-66.
13. Nakata T, Miyamoto K, Doi A, Sasao H, Wakabayashi T, Kobayashi H, et al. Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts. J Nucl Cardiol 1998;5:579-90.
14. Wakabayashi T, Nakata T, Hashimoto A, Yuda S, Tsuchihashi K, Travin MI, et al. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death. J Nucl Med 2001;42:1757-67.
15. Metra M, Faggiano P, D'Aloia A, Nodari S, Gualeni A, Raccagni D, et al. Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure. J Am Coll Cardiol 1999;33:943-50.
16. Glowniak JV, Turner FE, Gray LL, Palac RT, Lagunas-Solar MC, Woodward WR. Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants. J Nucl Med 1989;30:1182-91.
17. Takeishi Y, Atsumi H, Fujiwara S, Takahashi K, Tomoike H. ACE inhibition reduces cardiac iodine-123 MIBG release in heart failure. J Nucl Med 1997;38:1085-9.
18. Suwa M, Otake Y, Moriguchi A, Ito T, Hirota Y, Kawamura K, et al. Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to β-blocker therapy in patients with dilated cardiomyopathy. Am Heart J 1997;133:353-8.
19. 2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest 1998;102:1534-9.